tirzepatide grey market FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Eli Lilly's Tirzepatide and B12

Laboratory Monitoring & Clinical Assessment Framework GLP-1 receptor agonists do not require universal micronutrient screening in all patients

Since B12 is found solely in animal products, people with restricted diets often get very little B12, even if they eat synthetically fortified foods

consumers are currently trying to lose or maintain their weight, and weight management remains a top concern for many Americans

Important Safety Information for Wegovy WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures

Only authorised medicinal products are subject to regulatory control by competent authorities with regard to composition, quality, safety and efficacy

The cost difference is negligible compared to replacing a contaminated batch